SecuritySIEN / Sientra, Inc.
InstitutionVident Investment Advisory, LLC
Shares0
Value $ 0

Vident Investment Advisory, LLC closes position in SIEN / Sientra, Inc.

May 14, 2018 - Vident Investment Advisory, LLC has filed a 13F-HR form disclosing ownership of 0 shares of Sientra, Inc. (NASDAQ:SIEN) with total holdings valued at $0 USD as of March 31, 2018. Vident Investment Advisory, LLC had filed a previous 13F-HR on February 14, 2018 disclosing 34,186 shares of Sientra, Inc. at a value of $481,000 USD. This represents a change in shares of -100.00 percent and a change in value of -100.00 percent during the quarter.

Other investors with closed positions include Citadel Advisors Llc, Visium Asset Management, LP, Senzar Asset Management, Llc, Susquehanna International Group, Llp, and Financial Architects, Inc.

Sientra, Inc. has declared a standard industrial code (sic) of 3842 which is the "Orthopedic, Prosthetic, and Surgical Appliances and Supplies" industry. Vident Investment Advisory, LLC's top industries are "Agriculture production livestock and animal specialties" (sic 02), "Mining And Quarrying Of Nonmetallic Minerals, Except Fuels" (sic 14), and "Metal Mining" (sic 10).

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2018-03-31 13F-HR SIENTRA COM 82621J105 0 -100.00 0 -100.00 0 0
2017-12-31 13F-HR SIENTRA COM 82621J105 34,186 481

Related SEC Filings

SIEN / Sientra, Inc. / Abingworth LLP - SIENTRA 13D AMENDMENT NO. 1 (Activist Investment)

2018-05-09 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. 1) (2-0)

SIEN / Sientra, Inc. / Abingworth LLP - SIENTRA 13D AMENDMENT NO. 1 (Activist Investment)

2018-05-09 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Amendment No. 1) (2-0)

SIEN / Sientra, Inc. / CANNELL CAPITAL LLC - SCHEDULE 13G/A (Passive Investment)

2018-02-14 sec.gov
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2 (Amendment No.1) 1 Sientra, Inc. (Name of Issuer) Common Stock, par value $.01 per share (Title of Class of Securities) 82621J105 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant

SIEN / Sientra, Inc. / CANNELL CAPITAL LLC - SCHEDULE 13G/A (Passive Investment)

2018-02-14 sec.gov
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO §240.13d-2 (Amendment No.1) 1 Sientra, Inc. (Name of Issuer) Common Stock, par value $.01 per share (Title of Class of Securities) 82621J105 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant

SIEN / Sientra, Inc. / GILDER GAGNON HOWE & CO LLC - SC 13G (Passive Investment)

2018-02-14 sec.gov
    SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G (RULE 13d - 102)   INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2   (Amendment No.)*   Sientra, Inc. (Name of Issuer)   Common Stock, par value $0.01 per share (Title of Class of Securities)   8261J105 (CUSIP Number)   December 31, 2017 (Date of Event which Requires Filing of this Statement)   Check the appropriate box to designate the rule

Related News Stories

Are Options Traders Betting on a Big Move in Sientra (SIEN) Stock?

2018-10-12 zacks
Investors in Sientra, Inc. (SIEN - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 19, 2018 $25.00 Call had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other.

SEC sues U.S. breast-implant company's ex-CEO after stock dive

2018-09-19 reuters
(Reuters) - The U.S. Securities and Exchange Commission on Wednesday sued the founder and former chief executive of Sientra Inc (SIEN.O) for fraudulently concealing problems with his company’s breast and other implants as it was raising $61.4 million in a public stock offering.

SEC sues ex-CEO of California breast implant company after stock nosedived

2018-09-19 reuters
(Reuters) - The U.S. Securities and Exchange Commission on Wednesday sued the founder and former chief executive of Sientra Inc (SIEN.O) for fraudulently concealing problems with his company’s breast and other implants as it was raising $61.4 million in a public stock offering.

Your Daily Pharma Scoop: IPO Review - Aridis Files, Constellation And Establishment Price Their IPO

2018-07-25 seekingalpha
Like we said in the previous IPO review, the Fourth of July holidays brought in a lull in the IPO scene in the bio sector, which seems to have passed now. Here’s a further list of three new IPOs that proves our point. One major news doing the rounds and boosting the market up today is Eli Lilly’s (NYSE:LLY) plans to launch its animal health division Elanco as an IPO. Elanco, as you may know, is the largest vet meds company in the world; so an IPO will be good news for people looking to diversify.

U.S. IPO Weekly Recap: Bud, Biotechs, Banks And Breast Implants Make Gains In 9-IPO Week

2018-07-21 seekingalpha
The IPO market came back full force this week following the July 4th pause. Nine deals raised a combined $931 million, averaging a gain of 29%. (28-0)



CUSIP: 82621J105